NFKB1 and atherosclerosis: Gareus et al. previously demonstrated that inhibition of NF-κB activity through the deletion of IKKγ, also known as NF-κB essential modulator (NEMO), or expression of a dominant-negative IκBα decreases atherosclerosis in atherogenic prone mice (14).